Gustave Roussy’s French Cancer Centre Chooses Medsquare For Its Patient Dose Management Solution

Medsquare Logo
share Share

Medsquare has been selected by the Gustave Roussy Cancer Centre, which has chosen to be equipped by Medsquare’s Patient Dose Monitoring solution Radiation Dose Monitor (RDM). For this DACS acquisition project, signed via the French Purchasing group ’Resah’, Gustave Roussy has indicated that it wants to replace its existing DACS solution, notably expressing the need to recover and exploit data from its previous DACS.


Arnaud Legland, Medsquare’s Channel Sales Manager Europe, says: “We are delighted that Gustave Roussy has entrusted Medsquare with its project for the complete renewal and deployment of DACS. Collaborating with the premier European Cancer Centre is an honor for the Medsquare team. Moreover, replacing an existing DACS is a mission that we have already successfully completed, particularly at several levels (regional, hospitals and university hospitals).”


By becoming Gustave Roussy’s preferred partner, Medsquare is committed to being a key player in the Centre’s Patient Dose Management project, with the following objectives:
– Adapt the DACS RDM solution to the issues of Europe’s premier Cancer Centre in the fight against cancer, 
– Promote and value Gustave Roussy’s most innovative actions in patient dose monitoring,
– Provide Gustave Roussy with dedicated support throughout the use of the DACS RDM.


With RDM, patient dose data can be consolidated and used anonymously for research purposes. The goal is to share and use monitoring data (dose history) for clinical research at any time.


In addition, Gustave Roussy could be at the heart of a regional DACS in the Ile-de-France region as well as other establishments that also benefit from this regional dosimetry service. A deployment is currently underway at the Bordeaux University Hospital (the Krypton project in partnership with Carestream), which will soon benefit from this patient dose service in the French New Aquitaine region.


“The DACS project at Gustave Roussy is part of an initiative to raise the awareness of healthcare professionals about patient radiation protection, an approach that has been at the heart of Medsquare’s activity since 2010,” confirms Arnaud Legland. “With RDM, patient radiation protection professionals will be able to rely on powerful dose assessment tools that offer them the ability to control dose delivered to patients, facilitate data analysis, and remain alert to patient safety and thus improve the quality of care,” he adds.



«« RSNA 2019 Presents Session on Lung Injury from Vaping


RSNA 2019: Gunshot Injuries Have Long-term Medical Consequences »»

Published on : Thu, 28 Nov 2019



Related Articles
medsquare logo

Even today, finding the right balance between image quality and the radiation dose remains a core issue in medical imaging. Although... Read more

MEDSQUARE logo

The exceptional situation due to the spread of the coronavirus – as well as recent government directives – have led Medsquare... Read more

Medsquare logo

Protecting patients from over-exposure to radiation is part of the daily life of healthcare professionals in medical imaging.... Read more

Hospitals, Medsquare, DACS, Arnaud Legland, Cancer Center, Radiation Dose Monitor (RDM), Radiation Dose Monitor, RDM, Gustave Roussy Cancer Centre, Gustave Roussy, DACS solution, European Cancer Centre, university hospitals, DACS RDM, Bordeaux University Hospital Medsquare has been selected by the Gustave Roussy Cancer Centre, which has chosen to be equipped by Medsquare’s Patient Dose Monitoring solution Radiation Dose Monitor (RDM). For this DACS acquisition project, signed via the French Purchasing group ’Resah

No comment


Please login to leave a comment...

Highlighted Products